News
Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through ...
Novo Nordisk’s wildly popular GLP-1 drug Wegovy has been approved for use against a serious form of liver disease.
Benzinga on MSN41m
Novo Nordisk Jumps After FDA Grants Wegovy Approval For Liver Fibrosis, Unlocking Billions In Market Potential
Novo Nordisk shares rose Friday after the FDA granted accelerated approval for Wegovy to treat liver fibrosis in adults, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback